Can-Fite Biopharma GAAP EPS of $0.00, revenue of $0.2M (NYSE:CANF)

· Business · By ReportWire
  • Can-Fite Biopharma press release (NYSE:CANF): 1H GAAP EPS of $0.00.
  • Revenue of $0.2M (-35.5% Y/Y).
  • Can-Fite had cash and cash equivalents and short term deposits of $6.45 million as compared to $7.88 million at December 31, 2024. 

Source link